<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02337244</url>
  </required_header>
  <id_info>
    <org_study_id>CSE2013-07K</org_study_id>
    <nct_id>NCT02337244</nct_id>
  </id_info>
  <brief_title>Zimmer POLAR Persona - TKA (EMEA Study)</brief_title>
  <official_title>Persona Outcomes Led Assessment Research in Total Knee Arthroplasty (POLAR - TKA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer, GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to obtain implant survivorship and clinical outcomes
      data for commercially available Persona knee implants used in primary total knee
      arthroplasty. The assessment will include:

        1. Implant survivorship based on removal of a study device.

        2. Safety based on incidence and frequency of adverse events.

        3. Clinical performance measured by overall pain and function, quality of life data,
           radiographic parameters and survivorship.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multicenter, non-controlled study of the commercially available
      Persona knee implants. The study will require each site to obtain Ethics approval prior to
      study enrollment. All potential study subjects will be required to participate in the
      Informed Consent Process.

      Study subjects will undergo preoperative clinical evaluations prior to their total knee
      arthroplasty. The post-operative clinical and radiographic evaluations will be conducted at 5
      days to 6 weeks, 3 to 6 months, 1 year, 2, 3, 4, and 5 years after implantation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Kaplan-Meier Implant Survivorship</measure>
    <time_frame>5 years</time_frame>
    <description>Kaplan-Meier survivorship at 5 years with revision of any implant component, for any reason, as endpoint.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>'Knee injury and Osteoarthritis Outcome Score' (KOOS) subscale scores.</measure>
    <time_frame>5 years</time_frame>
    <description>The scores related to the five KOOS subscales calculated at different time points until 5 years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>'Forgotten Joint Score' (FJS-12)</measure>
    <time_frame>5 years</time_frame>
    <description>The score related to the FJS-12 patient-reported questionaire calculated at different time points until 5 years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxford Knee Score (OKS)</measure>
    <time_frame>5 years</time_frame>
    <description>The score related to the OKS patient-reported questionaire calculated at different time points until 5 years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol (EQ)-5D-3L score and EQ 'Visual Analog Scale' (VAS)</measure>
    <time_frame>5 years</time_frame>
    <description>The scores related to the EQ-5D-3L questionnaire and the EQ-VAS calculated at different time points until 5 years.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Severe Knee Pain</condition>
  <condition>Severe Knee Disability</condition>
  <condition>Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Traumatic Arthritis</condition>
  <condition>Polyarthritis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zimmer Persona Total Knee System</intervention_name>
    <description>No Intervention</description>
    <other_name>Primary Knee Replacement</other_name>
    <other_name>Total Knee Arthroplasty</other_name>
    <other_name>Total Knee Replacement</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary total knee arthroplasty subjects that receive the Zimmer Persona Total Knee System.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient 18-75 years of age, inclusive.

          -  Patient qualifies for primary total knee arthroplasty based on physical exam and
             medical history, including diagnosis of severe knee pain and disability due to at
             least one of the following:

               -  rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis;

               -  collagen disorders and/or avascular necrosis of the femoral condyle;

               -  post-traumatic loss of joint configuration, particularly when there is
                  patellofemoral erosion, dysfunction or prior patellectomy;

               -  moderate valgus, varus, or flexion deformities;

               -  the salvage of previously failed surgical attempts that did not include partial
                  or total knee arthroplasty of the ipsilateral knee.

          -  Patient is willing and able to complete scheduled study procedures and follow-up
             evaluations.

          -  Independent of study participation, patient is a candidate for commercially available
             Zimmer Persona knee implants implanted in accordance with product labeling.

        Exclusion Criteria:

          -  Patient is currently participating in any other surgical intervention studies or pain
             management studies.

          -  Previous history of infection in the affected joint and/or other local/systemic
             infection that may affect the prosthetic joint.

          -  Insufficient bone stock on femoral or tibial surfaces.

          -  Skeletal immaturity.

          -  Neuropathic arthropathy.

          -  Osteoporosis or any loss of musculature or neuromuscular disease that compromises the
             affected limb.

          -  Stable, painless arthrodesis in a satisfactory functional position.

          -  Severe instability secondary to the absence of collateral ligament integrity.

          -  Rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent
             breakdown of the skin.

          -  Patient has a known or suspected sensitivity or allergy to one or more of the implant
             materials.

          -  Patient is pregnant or considered a member of a protected population (e.g., prisoner,
             mentally incompetent, etc.).

          -  Patient has previously received partial or total knee arthroplasty for the ipsilateral
             knee.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Dominkus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopädisches Spital Speising, Wien, Austria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hendrik Verburg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stichting Research Orthopedie &amp; Reinier de Graaf Groep, Delf, Netherlands</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicholas London, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harrogate and District NHS, Harrogate, England</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stéphane Boisgard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Clermont-Ferrand, Clermont-Ferrand, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>François Canovas, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Lapeyronie, Montpellier</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pere Torner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Parc Tauli, Sabadell</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jon Clarke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Golden Jubilee National Hospital, Clydebank</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Deehan, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Freeman Hospital, Newcastle</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karl Dieter Heller, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>HEH Braunschweig</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fritz Thorey, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Atos Klinik Heidelberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fernando Martinez Delgado, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Miguel Servet Zaragoza</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Natalie Müller, MSc</last_name>
    <phone>+41 58 854 82 13</phone>
    <email>natalie.mueller@zimmerbiomet.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hassan Achakri, Msc, PhD</last_name>
    <phone>+41 58 854 82 03</phone>
    <email>hassan.achakri@zimmer.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Orthopädisches Spital Speising</name>
      <address>
        <city>Wien</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier régional Universitaire de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34980</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Canovas, Prof</last_name>
      <email>f-canovas@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>François Canovas, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HEH Braunschweig</name>
      <address>
        <city>Braunschweig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karl Dieter Heller, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Atos Klinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fritz Thorey, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stichting Research Orthopedie &amp; Reinier de Graaf Groep</name>
      <address>
        <city>Delft</city>
        <zip>2612</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Parc Tauli</name>
      <address>
        <city>Barcelona/Sabadell</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pere TORNER i Pifarré, MD</last_name>
      <email>ptorner@clinic.ub.es</email>
    </contact>
    <investigator>
      <last_name>Pere Torner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Martinez Delgado, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Golden Jubilee National Hospital</name>
      <address>
        <city>Clydebank</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Harrogate and District NHS</name>
      <address>
        <city>Harrogate</city>
        <zip>HG2 7SX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Newcastle Upon Tyne Hospitals</name>
      <address>
        <city>Newcastle</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Bardgett</last_name>
      <email>michelle.bardgett@nuth.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>David John Deehan, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Munawar Ahmad Hashmi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2015</study_first_submitted>
  <study_first_submitted_qc>January 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2015</study_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoarthritis</keyword>
  <keyword>Rheumatoid arthritis</keyword>
  <keyword>Traumatic arthritis</keyword>
  <keyword>Polyarthritis</keyword>
  <keyword>Total knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

